Search clinical trials for: BFKB8488A

Total 3 results

Genentech, Inc.

Terminated

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis (BANFF)

Non-alcoholic Steatohepatitis

Belgium, United States, Spain, Puerto Rico, France
Genentech, Inc.

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance

Insulin Resistance

United States
Genentech, Inc.

Completed

A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease

Diabetes Mellitus, Type 2 | Non-Alcoholic Fatty Liver Disease

United States, Canada

3

Subscribe